Superconductor-Based Readiness Enhanced Magnetoplasmadynamic Electric Propulsion

SUPREME aims to enhance the flight proficiency and commercial viability of AF-MPD thrusters using High-Temperature Superconductors for sustainable high-power electric propulsion in space applications.

Subsidie
€ 2.499.995
2023

Projectdetails

Introduction

High-power electric propulsion technology is needed to enable the sustainable realization of emerging market applications such as On-Orbit Servicing, in-space cloud computing, debris removal, and cis-lunar infrastructure. However, relevant technologies, in terms of cost-effectiveness, sustainability, and performance, are not yet available. The commercialization of new markets requires more scalable and flexible propulsion solutions.

Technology Overview

Applied-Field Magnetoplasmadynamic (AF-MPD) thrusters are a robust, efficient, and scalable Electric Propulsion technology, especially suited for high-power operations thanks to their high thrust levels and power densities. These benefits have motivated their widespread research since the 1960s.

Development Limitations

The main development limitations have been:

  1. Thruster lifetime
  2. Flight readiness imposed by the use of conventional copper magnets for generating the applied field.

These problems can be overcome with the use of High-Temperature Superconductors (HTS), which can provide the required magnetic field for AF-MPD operation in a compact and lightweight system.

Project Objectives

Under the leadership of NSS, a start-up commercializing HTS applications in space, SUPREME aims at:

  • Increasing the flight proficiency of AF-MPD by demonstrating the integration of HTS coils and all necessary supporting subsystems in a relevant environment.
  • Correspondingly increasing thruster performance and lifetime.
  • Validating the commercialization potential of the technology by generating a well-defined business model for achieving sustainable revenues and upscaling of production.

Consortium Composition

The consortium is completed by:

  • 2 Research Institutions (RIs)
  • An innovative Small and Medium-sized Enterprise (SME)
  • An Original Equipment Manufacturer (OEM)

Academic Contributions

On the academic side, both USTUTT and UT are institutes working at the forefront of disruptive R&D in the key areas of Electric Propulsion (EP), space cryogenics, and HTS systems.

Supply Chain and Industry Involvement

PEAK represents a key part of the supply chain for propellant tanks, and Airbus will contribute as both a supplier and potential first adopter of the technology.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 2.499.995
Totale projectbegroting€ 2.499.995

Tijdlijn

Startdatum1-6-2023
Einddatum30-11-2025
Subsidiejaar2023

Partners & Locaties

Projectpartners

  • UNIVERSITY OF STUTTGARTpenvoerder
  • COMPUTADORAS REDES E INGENIERIA SA
  • UNIVERSITEIT TWENTE
  • NEUTRON STAR SYSTEMS DE UG
  • PEAK TECHNOLOGY GMBH

Land(en)

GermanySpainNetherlandsAustria

Vergelijkbare projecten binnen EIC Transition

EIC Transition

Targeting cardiac fibrosis with next generation RNA therapeutics

FIBREX aims to develop an innovative ncRNA-based antisense oligonucleotide therapy targeting Meg3 to reverse cardiac fibrosis and treat heart failure, advancing towards clinical readiness.

€ 2.499.482
EIC Transition

automated in-line separatioN and dEtection of eXtracellular vesicles for liqUid biopsy applicationS

The NEXUS project aims to industrialize a customizable platform for the separation and analysis of extracellular vesicles from biofluids, enhancing cancer diagnostics and monitoring.

€ 2.497.750
EIC Transition

Predictive REagent-Antibody Replacement Technology stage 2-Translation

PRe-ART-2T aims to advance predictive antibody technology to TRL6, replacing low-quality monoclonal antibodies with high-performing synthetic alternatives, and attract ~€20M in investment.

€ 800.000
EIC Transition

Advancing a vaccine targeting genetic amyotrophic lateral sclerosis (C9orf72 ALS) to the clinical stage

Developing a poly-GA peptide vaccine to reduce protein aggregation and motor deficits in C9orf72 ALS, aiming for clinical evaluation and market entry through strategic partnerships.

€ 2.499.810

Vergelijkbare projecten uit andere regelingen

EIC Pathfinder

Ionic Propulsion in Atmosphere

This project aims to advance ionic air-breathing propulsion systems through research and development, ultimately designing a stratospheric airship to replace satellites with eco-friendly, cost-effective alternatives.

€ 2.999.993
EIC Pathfinder

COMPACT AND PROPELLANT-LESS ELECTRODYNAMIC TETHER SYSTEM BASED ON IN-SPACE SOLAR ENERGY

E.T.COMPACT aims to advance three in-space technologies for solar energy harvesting and green propulsion, enhancing efficiency and reducing costs for future space missions.

€ 3.972.890
EIC Pathfinder

Tau-E Breakthrough (TauEB): Infinite clean energy through fusion power to the grid & beyond

The Tau-E Breakthrough project aims to achieve stable, long-term plasma confinement for nuclear fusion using innovative plasma plugs, advancing fusion technology towards commercial viability and sustainable energy.

€ 2.944.905
EIC Pathfinder

Bimodal Ammonia Nuclear Thermal and Electric Rocket

BANTER aims to develop a compact bimodal nuclear thermal and electric propulsion system using ammonia, enhancing space mission capabilities and advancing green hydrogen production.

€ 2.997.300